ProAssurance Corporation

ProAssurance Corporation (PRA) Market Cap

ProAssurance Corporation has a market capitalization of $1.28B.

Price: $24.71

0.18 (0.73%)

Market Cap: 1.28B

NYSE · time unavailable

CEO: Edward Lewis Rand Jr.

Sector: Financial Services

Industry: Insurance - Property & Casualty

IPO Date: 1991-09-04

Website: https://www.proassurance.com

ProAssurance Corporation (PRA) - Company Information

Market Cap: 1.28B|Sector: Financial Services

Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Lloyd's Syndicate segments. It offers professional liability insurance for healthcare providers and institutions, and attorneys; liability insurance for medical technology and life sciences risks; and workers' compensation insurance, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Lloyd's of London Syndicate 1729, which underwrites property and casualty insurance, and reinsurance. It markets its products through independent agencies and brokers, as well as an internal sales force. The company was founded in 1976 and is headquartered in Birmingham, Alabama.

Analyst Sentiment

23%
Underperform

From 4 Active Polls

1Y Forecast: $18.33

▼ -25.8% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$18

High Bound

$20

Average

$18

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$18.33
▼ -25.82% Upside
Low Target
$17.00
-31% Risk
Median Target
$18.00
-27% Mid
High Target
$20.00
-19% Max
Consensus
Hold
2 / 11 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,2751,2731,2421,2331,1721,195814773631
Enterprise Value ($M)1,6941,6921,6411,6161,5691,5921,2011,1721,038
Price to Earnings Ratio (P/E)19.5237.619.31213.2513.37-51.3212.5811.7510.17
Price/Earnings-to-Growth Ratio (PEG)218.698.739.30
Price to Sales Ratio (P/S)1.184.854.614.494.314.462.862.752.24
Price to Book Ratio (P/B)0.950.950.920.950.920.970.680.630.56
Price to Free Cash Flow Ratio (P/FCF)-33.20-59.10-94.0651.30-42.30-99.94-313.1676.73-43.22
Enterprise Value to Sales (EV/Sales)6.446.085.885.775.944.234.183.69
Enterprise Value to EBITDA (EV/EBITDA)13.9998.4129.92125.1343.35600.8042.6338.1937.07
Debt to Equity Ratio3.460.320.320.330.340.360.370.360.39

PRA Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$24.71
Intrinsic Value$14.58
Market Alignment
Overvalued by 41.0%relative to calculated intrinsic value
9.00%
Exp: -1%-1%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.08B
Perpetuity TV Value$1.56B
Discounted TV (PV)$0.66B
TV Weighting %56.5%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 PROASSURANCE CORP (PRA) — Investment Overview

🧩 Business Model Overview

PROASSURANCE CORP (PRA) operates as a specialist property & casualty insurer, with a concentration in professional liability—particularly medical professional liability. The business model follows a long-tail insurance value chain: PRA underwrites policies based on actuarial pricing and risk selection, collects premiums upfront, and then pays claims as they develop over time. This structure makes pricing discipline, reserve setting, and claims management central to economic outcomes.

Practical “how it works” is driven by (1) underwriting and pricing competence (setting rates that reflect risk), (2) disciplined claims handling and loss mitigation, and (3) capital and reinsurance strategy that ensures PRA can survive adverse claim development while continuing to write business.

💰 Revenue Streams & Monetisation Model

PRA monetises primarily through earned premiums from long-tail professional liability policies. The dominant margin drivers are:

  • Underwriting margin: governed by the relationship between premium and loss/expense costs, typically expressed through the combined ratio framework.
  • Reserve adequacy: since claims develop over time, favorable or unfavorable prior-year reserve development can materially affect profitability.
  • Investment income: investment returns on the float (premiums collected before claims are paid) contribute to total earnings, with credit and duration management influencing realized outcomes.

While premium growth can support revenue expansion, PRA’s earnings quality hinges more on underwriting and reserving discipline than on transactional volume alone.

🧠 Competitive Advantages & Market Positioning

PRA’s moat is primarily rooted in underwriting expertise and reserving discipline, supported by capital and reinsurance access that allow the company to remain active through unfavorable loss environments.

  • Regulatory-capital and operating friction (regulatory moat): Insurance underwriting is constrained by capital requirements, rating/solvency expectations, and compliance processes. This raises barriers for new entrants and for competitors attempting rapid scaling in specialized lines.
  • Claims and actuarial know-how (credit/claims culture): Long-tail professional liability requires robust actuarial pricing, underwriting selection, and reserving discipline. Repeated cycles reward firms that can maintain accuracy in underwriting and claim development expectations.
  • Relationship-driven persistence (soft switching costs): In professional liability, coverage decisions often involve incumbent familiarity with loss history, broker relationships, and institutional underwriting requirements—creating friction that tends to favor established carriers during normal market conditions.
  • Reinsurance and capital market credibility: Specialty insurers compete for reinsurance capacity and favorable terms. Proven loss management and capital strength can support better reinsurance outcomes over time.

COMPETITIVE BENCHMARKING (industry comparables):

  • The Doctors Company — a medical professional liability specialist. PRA’s focus is similarly oriented toward healthcare professional risk, but PRA’s competitive posture depends on underwriting selectivity and reserving accuracy relative to this specialist peer.
  • MedPro Group (Medical Protective, Berkshire Hathaway) — a major participant in professional liability. MedPro is broader in professional lines, whereas PRA emphasizes specialist execution in its targeted segments, which can influence underwriting outcomes across the cycle.
  • Chubb — a diversified global insurer with professional liability offerings. Chubb competes with scale and diversification; PRA’s differentiation relies less on breadth and more on specialization, pricing discipline, and claims/reserve execution in long-tail healthcare-related exposures.

Key contrast: diversified carriers can offset underwriting volatility with other lines, while specialists like PRA compete through precision in risk selection and the accuracy of long-tail reserving—where sustained performance is difficult to replicate without deep underwriting infrastructure.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, PRA’s growth outlook is shaped less by “market share capture” and more by favorable industry fundamentals and the ability to maintain disciplined underwriting within a changing risk environment:

  • Long-tail exposure expansion: Persistent demand for medical professional liability coverage supports policy renewal and replacement needs as providers maintain coverage for regulatory, contractual, and risk-management reasons.
  • Litigation and severity dynamics: Professional liability losses tend to be influenced by legal climate, medical practice complexity, and claim severity. Carriers with strong pricing discipline can gain profitability when the industry re-prices risk.
  • Underinsurance and coverage gaps: In periods of tightened underwriting standards, remaining market capacity often shifts toward carriers that can demonstrate underwriting rigor and claims management competence.
  • Capital and reinsurance optimization: Better reinsurance structuring and capital allocation can enable more stable underwriting and the ability to write risk without compromising risk-adjusted returns.

⚠ Risk Factors to Monitor

  • Reserve adequacy risk: Long-tail professional liability requires accurate loss estimates. Adverse reserve development can impair earnings and book value.
  • Underwriting cycle dynamics: Softening pricing or increasing competition can pressure margins and create a mismatch between earned premiums and expected losses.
  • Regulatory and rate-change constraints: Insurance regulation and rate filing requirements can limit how quickly premiums adjust to changing loss trends.
  • Investment risk to float: Credit quality, duration exposure, and market volatility affect investment income and realized losses, especially when underwriting margins compress.
  • Reinsurance cost and availability: Reinsurance market conditions can increase costs or reduce coverage capacity, affecting net retention and profitability.

📊 Valuation & Market View

Insurance markets typically evaluate PRA-type specialty insurers through a lens focused on capital durability and underwriting profitability rather than purely top-line growth. Common valuation frameworks include:

  • Price-to-book and return on equity expectations: reflects the market’s view of achievable profitability and the sustainability of capital.
  • Underwriting performance and reserve trends: combined ratio mechanics and the credibility of reserve development drive confidence in future earnings.
  • Investment income resilience: the quality of the investment portfolio and its ability to support total returns across cycles.
  • Capital strength and reinsurance strategy: affects downside protection and underwriting capacity.

Drivers that tend to move the needle include the trajectory of underwriting profitability, evidence of reserving accuracy, and management’s demonstrated ability to balance growth with risk selection and capital discipline.

🔍 Investment Takeaway

PROASSURANCE CORP’s long-term value proposition rests on specialist execution in medical professional liability—where repeatable underwriting selection, claims/reserving discipline, and capital/reinsurance credibility can compound through cycles. The key investment question is not premium growth alone, but whether PRA can consistently translate premium into durable risk-adjusted earnings while maintaining reserve accuracy and capital resilience.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for PRA.

zacks.com2026-06-04

Why Is ProAssurance (PRA) Down 0.7% Since Last Earnings Report?

ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?

gurufocus.com2026-05-19

Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients

[url="]Verici Dx plc[/url] (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced the publication of a peer-reviewed c

zacks.com2026-05-12

ProAssurance Q1 Earnings Meet Estimates on Declining Expenses

PRA matches Q1 earnings estimates as lower expenses and higher investment income help offset declines in premiums across segments.

zacks.com2026-05-05

ProAssurance (PRA) Matches Q1 Earnings Estimates

ProAssurance (PRA) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.13 per share a year ago.

zacks.com2026-05-05

ProAssurance (PRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for ProAssurance (PRA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

businesswire.com2026-05-05

ProAssurance Reports Results for First Quarter 2026

BIRMINGHAM, Ala,--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $8.5 million, or $0.16 per diluted share, and operating income(1) was $12.7 million, or $0.25 per diluted share, for the three months ended March 31, 2026. Highlights(2) Operating performance continues to demonstrate progress toward premium rate levels appropriate for the challenging conditions in.

zacks.com2026-04-29

Hanover Insurance Group (THG) Surpasses Q1 Earnings Estimates

Hanover Insurance Group (THG) came out with quarterly earnings of $5.25 per share, beating the Zacks Consensus Estimate of $4.14 per share. This compares to earnings of $3.87 per share a year ago.

zacks.com2026-04-29

Skyward Specialty Insurance (SKWD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Skyward (SKWD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-04-28

ProAssurance (PRA) Earnings Expected to Grow: What to Know Ahead of Q1 Release

ProAssurance (PRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

defenseworld.net2026-04-04

JPMorgan Chase & Co. Purchases 58,382 Shares of ProAssurance Corporation $PRA

JPMorgan Chase and Co. grew its position in ProAssurance Corporation (NYSE: PRA) by 58.7% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 157,891 shares of the insurance provider's stock after buying an additional 58,382 shares during the period. JPMorgan Chase and Co. owned approximately 0.31%

zacks.com2026-03-27

All You Need to Know About ProAssurance (PRA) Rating Upgrade to Strong Buy

ProAssurance (PRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

zacks.com2026-03-25

ProAssurance (PRA) Up 0.9% Since Last Earnings Report: Can It Continue?

ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?

zacks.com2026-03-19

Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA

Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.

zacks.com2026-02-27

What Makes ProAssurance (PRA) a Strong Momentum Stock: Buy Now?

Does ProAssurance (PRA) have what it takes to be a top stock pick for momentum investors? Let's find out.

defenseworld.net2026-02-26

ProAssurance Corporation (NYSE:PRA) Given Average Recommendation of “Reduce” by Analysts

Shares of ProAssurance Corporation (NYSE: PRA - Get Free Report) have been assigned a consensus recommendation of "Reduce" from the six analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 1 year

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"PRA (Q1’26 ended 2026-03-31) reported revenue of $262.6M and net income of $8.46M (EPS $0.16). On a year-over-year basis, revenue was essentially flat vs Q1’25 ($262.6M vs $268.1M; -2.0% YoY), while net income swung from a loss to profit ($8.46M vs -$5.82M; +$14.3M improvement YoY). Sequentially, results strengthened: revenue declined slightly QoQ (-2.6% from $269.6M in Q4’25), but net income rose sharply (+153% QoQ from $33.4M in Q4’25? actually Q4 net income was $33.37M; therefore net income decreased QoQ by -74.6%). Profitability was mixed across the last four quarters: Q1’26 net margin was 3.2%, below Q4’25 (12.4%) and above Q3’25 (0.5%) but below the stronger periods. Operating income was $12.7M (4.8% margin), indicating improved cost discipline versus the weaker Q1’25 (-6.3M operating income). Cash flow disclosures show net income is not reconciled to OCF in this dataset for Q1’26 (operating cash flow reported as 0), but the company has remained liquid: cash & short-term investments fell to $323.6M from $4.13B in Q4’25, while total equity was stable around $1.34B. Shareholder returns appear driven more by valuation/price stability than by momentum: the stock is up +5.8% over 1 year and shows no >20% 1y_change tailwind. No dividends or buybacks were indicated in the provided cash flow lines."

Revenue Growth

Caution

Revenue was -2.0% YoY in Q1’26 ($262.6M vs $268.1M) and -2.6% QoQ ($262.6M vs $269.6M). Mild contraction with no clear acceleration.

Profitability

Neutral

Net income improved dramatically YoY (from -$5.82M in Q1’25 to +$8.46M in Q1’26), but was weaker sequentially vs Q4’25 (net income down from $33.37M to $8.46M). Net margin in Q1’26 was 3.2%—above Q3’25 but below Q4’25.

Cash Flow Quality

Neutral

Q1’26 operating cash flow is reported as 0 in the dataset, limiting confidence in cash conversion. Prior quarters show both positive and negative OCF (e.g., Q3’25 positive OCF; Q2/Q4’25 negative). Dividends were 0 across quarters shown.

Leverage & Balance Sheet

Neutral

Balance sheet equity was stable (~$1.34B). Net debt improved materially to ~-$0.08M (net cash) in Q1’26 from large net debt positions in 2025, and liquidity remains supported by sizable cash & short-term investments.

Shareholder Returns

Fair

Total return signals are modest: price is +5.8% over 1 year with no strong momentum (not >20%). Cash flow lines show no dividends or buybacks, so returns likely rely on price/valuation rather than distributions.

Analyst Sentiment & Valuation

Fair

Current price $24.65 vs consensus target ~$18.33 implies the stock is trading above the provided street targets (limited upside based on those figures). High P/E in the ratio set reflects prior volatility in earnings.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

ProAssurance’s Q4 call highlights improving underwriting performance but underlines that the core problem—medical severity inflation—has not gone away. Management leaned positive on Specialty P&C, citing a 101% Q4 combined ratio driven by ~9 points of favorable prior accident-year reserve development and a full-year improvement to 104%. However, the quarter was also marred by a non-operational earnings drag: accelerating Lloyd’s runoff losses cut Q4 net income by $5.3M (~$0.10/share) and added ~3 points to the segment combined ratio impact. In the Q&A, analysts pressed on whether competition is changing and how workers’ comp can push rate. Management was explicit that competition remains capital-rich and aggressive but that PRA will prioritize rate adequacy over growth. The more candid hurdle: workers’ comp rating bureau loss-cost declines are being driven by frequency and may be stale, while management believes severity is still rising—creating a “push rate in a declining indication” challenge. Overall tone is confident, but the operational headwinds are still very real.

AI IconGrowth Catalysts

  • Specialty P&C combined ratio of 101% in Q4 2024 benefiting from almost nine points of favorable prior accident year reserve development
  • Full-year Specialty P&C combined ratio improved sequentially by nearly five points to 104% (including almost six points of favorable development)
  • Over 20 points of improvement in accident year loss and LAE ratio since 2019 (driven by renewal premium increases plus re-underwriting efforts)
  • Workers’ comp: combined ratio improved for the quarter and full year vs 2023 supported by integrated policy/claims/risk management/billing system implemented in early 2024
  • Initial implementation of Clari Analytics claim-specialist partnership (medical outcomes, case reserve estimation, reduced administrative burden)
  • AI-ready web portal launched in late 2024 (self-service for policyholders/agents) and process to file fully revised policy forms/manuals for standard business nationwide

Business Development

  • Clari Analytics partnership for workers’ compensation claim and medical management tools (document intelligence/directing care; high-severity claim early identification)
  • AI-ready web portal for policyholders and agents (late 2024) to improve ease of doing business with insureds and distribution partners
  • No material changes in agency/distribution relationships stated for 2025 outlook

AI IconFinancial Highlights

  • Operating earnings for full year: $0.95 per share; operating ratio: 94.5%
  • Specialty P&C Q4 2024 segment combined ratio: 101% including almost nine points of favorable prior accident year reserve development
  • Specialty P&C full-year combined ratio: 104% (improved sequentially by nearly five points; including almost six points of favorable development); core ongoing operations combined ratio improved due to favorable development in accident years 2021 and prior; net loss ratio 76.9%
  • Lloyd’s runoff housekeeping impact: accelerated reporting due to IBNR increase from aviation risks (Syndicate 6131, 2021 year) reduced Q4 net income by $5.3 million (~$0.10/share); Specialty P&C combined ratio impact about three points
  • Medical professional liability (MPL) renewal premium increases: 10% for standard MPL in Q4; 8% for specialty portion of MPL in Q4
  • MPL renewal premium increases since 2018: almost 70% cumulatively
  • Retention exclusive of rate changes: 83% in the quarter (strong retention in standard book)
  • Workers’ comp: net written premiums up only $4 million for the year (higher audit premiums offsetting improved renewal pricing); new business in traditional book more than $4 million below last year
  • Workers’ comp renewal rate change: state-mandated loss cost decreases produced slower rate decline to 2% vs 5% in prior year
  • Workers’ comp full-year combined ratio: 114%; current net loss ratio 77% (four points below 2023); Q4 and full-year favorable prior accident year reserve development: $0.5 million (vs 2023 reserve strengthening)

AI IconCapital Funding

  • No explicit buyback dollar amount disclosed in the transcript; management reiterated repurchase is considered but framed in context of operating subsidiary capital needs and debt levels
  • Investment leverage: 3.5 times GAAP equity (used as an indicator of ability/intent to hold fixed maturity securities until maturity)

AI IconStrategy & Ops

  • AI/analytics initiatives: predictive analytics for geographic markets/subsectors; AI-ready web portal; filing revised policy forms/manuals for nationwide standard business; underwriting tools using data analytics to expand penetration in more profitable small account segment
  • Workers’ comp operations: leveraging integrated policy/claims/risk management/billing system from early 2024; ramping tool to optimize network and medical management partners
  • Discipline on underwriting appetite: continuing to forego renewal and new business opportunities not meeting rate adequacy expectations in current loss environment
  • Claims/reserving discipline: positive prior accident year reserve development cited for MPL and workers’ comp

AI IconMarket Outlook

  • Specialty P&C competition trajectory: management does not see anything different in Q4 vs 2024 and expects similar competitive conditions in 2025; profitability over growth remains the mantra
  • MPL 2025 outlook: expect continued pushing of rate as hard as possible; guidance phrased as making 2025 look like 2024
  • Workers’ comp 2025 outlook: a lot like 2024; managed to keep rate almost flat in a market with loss-cost multipliers down; objective remains to push hard for adequate rates on an individual account basis

AI IconRisks & Headwinds

  • Continuing social inflation and erosion of tort reform driving a challenging legal environment (exacerbated by legal system abuse)
  • Underwriting appetite constraint: company continues to forgo renewal/new business not meeting rate adequacy expectations
  • Specialty MPL Q4 headwinds included recognition of loss severity trends in a few jurisdictions; also quarter-over-quarter comparison impacted by lowered estimate of unallocated loss adjustment expenses and year-over-year change in premium ceded to reinsurers
  • Workers’ comp headwind/operational hurdle: rating bureau loss cost indications trend down due to claim frequency decline, but management believes they are stale and not factoring severity rising within workers’ comp; challenge is to push rate in a market with loss cost indications that are declining
  • Agency economics risk: private equity consolidation in agency space expected to continue pressuring commission levels/expectations into 2025
  • Capital adequacy risk framed via need to keep RBCs solidly stable; management did not provide exact RBC target/level in transcript

Sentiment: MIXED

Note: This summary was synthesized by AI from the PRA Q4 2024 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for PRA.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (PRA)

© 2026 Stock Market Info — ProAssurance Corporation (PRA) Financial Profile